A letter from the Council for Economic Education to a special committee of the European Parliament in late April marked the most recent development in the pharmaceutical industry's efforts to protect the world's forests.The letter stated that the pharmaceutical industry cannot create new medications without the plants and trees that serve as the foundation for many existing ones, and it urged funding for developing nations. Consequently, businesses that transport the majority of their products to the European Union—a big export market—are attempting to lessen their carbon footprint. This may appear to have a lot of fine print.The lengthy shipping routes taken by pharmaceutical businesses, however, cloud the issue of how to lower greenhouse gas emissions at the EU level by concentrating on the production and distribution of chemicals.